Literature DB >> 10984152

Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres.

C N O'Brien1, A J Guidry, A Fattom, S Shepherd, L W Douglass, D C Westhoff.   

Abstract

Staphylococcus aureus is responsible for a major portion of the economic losses due to mastitis. Attempts to produce a vaccine to prevent S. aureus mastitis have been hampered by the low immunogenicity of the polysaccharide, which forms on the surface of the organism when it enters the mammary gland. The polysaccharide inhibits phagocytosis and destruction of the organism by neutrophils. This study was conducted to determine if S. aureus polysaccharide serotypes 5, 8, and 336 conjugated to a protein and incorporated in poly(DL-lactide-co-glycolide) microspheres would enhance the production of opsonizing antibodies to the polysaccharide. Cows were immunized with either polysaccharide conjugates emulsified in Freund's incomplete adjuvant or polysaccharide conjugates encapsulated in poly (DL-lactide-co-glycolide) microspheres emulsified in Freund's incomplete adjuvant. All cows produced sustained antibody titers to the three polysaccharide serotypes. Cows immunized with microspheres had higher antibody titers. Cows in both groups produced increased concentrations of IgG1 and IgG2 antibodies; neither group produced an increase in IgM. Immune sera from cows immunized with conjugates alone increased phagocytosis, which decreased at the end of the study. Sera from cows immunized with conjugates in microspheres increased phagocytosis, which was sustained at the end of the study. Immune sera from both groups decreased bacterial adherence to bovine mammary epithelial cells. These data showed that a single injection of antigen in microspheres produced higher titers and more sustained enhancement of phagocytosis, which could aid in the defense of the cow against S. aureus infections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10984152     DOI: 10.3168/jds.S0022-0302(00)75046-6

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  5 in total

1.  Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.

Authors:  Isabelle Verdier; Geraldine Durand; Michele Bes; Kimberly L Taylor; Gerard Lina; François Vandenesch; Ali I Fattom; Jerome Etienne
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

2.  Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis.

Authors:  Jai-Wei Lee; Celia N O'Brien; Albert J Guidry; Max J Paape; Kimberley A Shafer-Weaver; X Zhao
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

Review 3.  Nanovaccines: recent developments in vaccination.

Authors:  Tarala D Nandedkar
Journal:  J Biosci       Date:  2009-12       Impact factor: 2.795

4.  Detection of capsular genotypes of methicillin-resistant Staphylococcus aureus and clonal distribution of the cap5 and cap8 genes in clinical isolates.

Authors:  Gabriela Echániz-Aviles; Maria Elena Velazquez-Meza; Brian Rodríguez-Arvizu; Maria Noemi Carnalla-Barajas; Araceli Soto Noguerón
Journal:  Arch Microbiol       Date:  2022-02-21       Impact factor: 2.552

Review 5.  Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.

Authors:  Michael R Yeaman; Scott G Filler; Clint S Schmidt; Ashraf S Ibrahim; John E Edwards; John P Hennessey
Journal:  Front Immunol       Date:  2014-09-26       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.